Larvol Delta - Safety-and-immunogenicity-of-a-modified-COVID19-mRNA-vaccine-SWBIC213-as-a-heterologous-booster-in-healthy-adults-an-openlabeled-twocentered-and-multiarm-randomised-phase-1-trial

SW-BIC-213 - Stemirna Therap

COVID-19 mRNA vaccine - China CDC, Tongji University, Stemirna Therap

http://www.ncbi.nlm.nih.gov/pubmed/37099843

Apr 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next